Teams

Sector

Any Advance Materials Aerospace AI Big Data Diagnostic Hardware/Instrumentation Industrial Manufacturing Life Safety Medical Device Medical Technology Mobility Optics Robotics Software Sustainability/Clean Tech Therapeutics

Stage

Any Pre-Seed Seed Series A Series B Series C

Nemea Therapeutics
from Baylor College of Medicine.
Nemea Therapeutics is a preclinical-stage company developing oral small molecule inhibitors targeting mitochondrial RNA polymerase (POLRMT) for the treatment of mitochondria-dependent solid tumors.

…
Read More